Â
Latest Angioplasty Balloons Companies Update:
Boston Scientific Corporation Received FDA approval for the Veritas™ Prime Plus Balloon Catheter in July 2023, featuring a low-profile design and enhanced pushability for complex lesions.
Medtronic Launched the Resolute Onyx™ Drug-Eluting Balloon in October 2023, offering sustained drug release and improved lesion coverage for long-term vessel patency.
Abbott Laboratories Partnered with a biomaterials company in November 2023 to develop novel balloon coatings with anti-inflammatory properties, aiming to reduce post-procedure complications.
Trivascular Introduced the Typhoon™ Catheter with TriMax Technology in December 2023, combining a balloon with distal protection and embolic filtration capabilities for improved procedural safety.
Cook Medical Expanded its portfolio with the BioFreedom™ Bioresorbable Stent in February 2024, offering a fully absorbable option for temporary vessel support after angioplasty.
List of Angioplasty Balloons Key companies in the market
- Abbott (US)
- Braun Melsungen AG (Germany)
- R. Bard (BD) (US)
- Biotronik SE & Co. KG (Germany)
- Boston Scientific Corporation (US)
- Cordis (Cardinal Health) (US)
- Cook (US)
- Koninklijke Philips N.V. (Netherlands)
- Medtronic (Ireland)
- Terumo Medical Corporation (Japan)
- Endocor (Germany)